Institutional investors purchased a net $6.5 million shares of IMMU during the quarter ended June 2014, and now own 41.91% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.6 Million shares of Immunomedics Inc
RA CAPITAL MANAGEMENT LLC Bought 1.0 Million shares of Immunomedics Inc